Comparision of the Use in Marcaine and Chloroprocaine in Rachianesthesia for the Surgical Correction of Inguinal Hernia.
NCT ID: NCT02049255
Last Updated: 2014-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
50 participants
INTERVENTIONAL
2013-11-30
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Hyperbaric Prilocaine With Chloroprocaine for Intrathecal Anaesthesia in Day Case Knee Arthroscopy
NCT03038958
Intrathecal Analgesia for Normal Labour
NCT04221568
Effect of Intraoperative Infiltration With Bupivacain on the Development of Chronic Pain After Inguinal Hernia Repair
NCT00484731
Efficacy of Pre-operative Oral Pregabalin in Ambulatory Inguinal Hernia Repair for Post Operative Pain
NCT01450345
A Comparison of Bupivacaine and 2-chloroprocaine for Spinal Anesthesia
NCT00845962
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Marcaine
Rachianesthesia with marcaine or chloroprocaine
Marcaine
The Group "Marcaine" will receive: Marcaine: 12,5 mg in rachianesthesia
Chloroprocaine
Rachianesthesia with marcaine or chloroprocaine
Chloroprocaine
The Group "Chloroprocaine" will receive: Chloroprocaine: 50 mg in rachianesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chloroprocaine
The Group "Chloroprocaine" will receive: Chloroprocaine: 50 mg in rachianesthesia
Marcaine
The Group "Marcaine" will receive: Marcaine: 12,5 mg in rachianesthesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* ASA 4
* Emergency
* Combined surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric DEFLANDRE, MD, FCCP
Eric DEFLANDRE, MD, FCCP
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric P Deflandre, MD, FCCP
Role: PRINCIPAL_INVESTIGATOR
Astes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Saint-Luc Bouge
Bouge, Namur, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMBES-ASTES-2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.